caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1578565610

William GraceM.D.

Medical OncologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where William Grace's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
703,038
LENOX HILL HOSPITAL38426
JAVIT, DANIEL12108
Dimitry Hikin
Diagnostic Radiology · Long Island City, NY
1271
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,371
Unique beneficiaries
—
Total services
53,235
Distinct HCPCS
57
Medicare payment
$553K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 506 Medical Oncology providers in NY — top quintile (cohort median 458).
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
15.8
Cost
75.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
837
Beneficiaries
—
Total drug cost
$3.9M
Distinct drugs
31
Brand share
58.9%
Top prescribed drugs
Letrozole69 claims
Fosnetupitant/Palonosetron61 claims
Enzalutamide59 claims
Palbociclib57 claims
Darbepoetin Alfa In Polysorbat56 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.